RxDoctor Payments Data

John Stafford, MD

Family Medicine · Saint Joseph, MINPI 1730182247

Payments from drug & device makers

$5,627in general payments, 2019–2025

Across 369 payments — averaging $15.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$772
  • AbbVie$573
  • GSK$498
  • Lilly USA, LLC$424
  • AstraZeneca$369
  • Boehringer Ingelheim$332
  • plus $3K from 25 others

What the payments were for

  • Food & beverage$5,58799%
  • Education$401%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,627 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$76,811
Medicare patients
188
Services billed
1,114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban119$128,918
JardianceEmpagliflozin57$66,524
JanuviaSitagliptin Phosphate32$33,442
FarxigaDapagliflozin Propanediol25$29,016
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$24,669
XareltoRivaroxaban24$24,447
OzempicSemaglutide17$19,372
Nurtec OdtRimegepant Sulfate19$18,970
Breo ElliptaFluticasone/Vilanterol14$11,878
LinzessLinaclotide14$9,369
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen323$8,112
Aripiprazole22$7,189
Atorvastatin Calcium383$6,016
Tamsulosin Hcl141$4,095
Losartan Potassium287$3,613

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$289$147,888138 claims
Boehringer IngelheimJardiance$332$66,52457 claims
GSKTrelegy Ellipta, Breo Ellipta$498$36,54837 claims
MerckJanuvia$329$33,44232 claims
AstraZenecaFarxiga$369$29,01625 claims
Johnson & JohnsonXarelto$241$24,44724 claims
Novo NordiskOzempic$772$19,37217 claims
AbbVieLinzess$573$9,36914 claims
Almatica Pharma LLCSertraline Hcl$50$1,08868 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Saint Joseph

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →